Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12.62 USD | +0.08% | -0.24% | +3.95% |
05-14 | Centogene, Evotec Discover New Molecule for Potential Gaucher Disease Treatment | MT |
04-30 | Evotec, Bayer to Collaborate on New Cardiovascular Disease Therapies | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+12.07% | 9.59B | |
-0.20% | 5.58B | |
+8.62% | 5.5B | |
+6.77% | 5.24B | |
+28.01% | 4.84B | |
+23.26% | 4.61B | |
+2.73% | 4.13B | |
+7.31% | 4.05B | |
-0.18% | 3.28B |
- Stock Market
- Equities
- EVO Stock
- News Eaton Vance Ohio Municipal Income Trust
- Deutsche Bank Downgrades Evotec SE to Hold From Buy After Weaker-Than-Expected Q3 Results, Cuts Price Target to EUR21 From EUR26